Related Experiment Video
Updated: Jun 26, 2025
05:07
Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
586
A decade's experience with retrograde open mesenteric stenting for acute mesenteric ischemia
Salim G Habib1, Dana B Semaan1, Elizabeth A Andraska1
1Division of Vascular and Endovascular Surgery, Charleston Area Medical Center, Charleston, WV.
Journal of Vascular Surgery
|May 16, 2024
Summary
Retrograde open mesenteric stenting (ROMS) offers a successful treatment for acute mesenteric ischemia (AMI), demonstrating good technical outcomes. This approach provides rapid revascularization and allows for necessary bowel assessment, making it a viable alternative for AMI management.
Area of Science:
- Vascular Surgery
- Gastrointestinal Surgery
- Interventional Cardiology
Background:
- Acute mesenteric ischemia (AMI) carries high mortality rates.
- Retrograde open mesenteric stenting (ROMS) is an alternative to mesenteric bypass for AMI.
- Limited large-scale studies evaluate ROMS outcomes.
Purpose of the Study:
- To assess the outcomes of ROMS in patients with AMI.
- To evaluate in-hospital, 30-day, and 1-year mortality rates.
- To analyze postoperative complications and stent patency.
Main Methods:
- Retrospective review of 42 AMI patients treated with ROMS (2011-2022).
- Analysis of demographics, presentation, operative details, and outcomes.
- Kaplan-Meier estimates for mortality and patency; assessment of complications.
Main Results:
- Technical success achieved in 95.2% of cases.
- 30-day mortality was 22.5%; 1-year survival was 58.6%.
- Common complications included sepsis (20.0%); 80.0% required bowel resection.
Conclusions:
- ROMS demonstrates high technical success in AMI management.
- Mortality rates appear lower than traditionally reported for AMI.
- ROMS offers rapid revascularization and bowel evaluation, serving as an alternative treatment modality.
